期刊文献+

胰腺导管腺癌TPAP基因的表达及其与临床病理和预后的关系 被引量:1

Relationship between the expression of TPAP gene in pancreatic ductal cancer and its clinical features and prognosis
下载PDF
导出
摘要 目的探讨胰腺导管腺癌组织中TPAP基因表达与患者临床特征及预后之间的关系。方法采用实时定量RT-PCR方法检测40例胰腺导管腺癌、相应的癌旁胰腺组织及5例尸检获得的正常胰腺组织中TPAPmRNA的表达情况,并分析TPAP基因检测结果与临床病理参数和预后之间的关系。结果 TPAP在胰腺癌组织中的相对表达量[0.012(0.004,0.018)]明显低于癌旁组织[0.018(0.009,0.081)]及正常胰腺组织[0.740(0.457,0.891),P<0.01],后两者之间表达也有明显差异(P<0.001)。癌组织中TPAPmRNA的相对表达量与远处转移呈负相关(r=-0.342,P=0.031),与高分化呈正相关(r=0.371,P=0.018),但肿瘤部位和大小、血清CA19-9浓度、血清CEA浓度、临床分期、淋巴转移、患者的性别和年龄均对TPAP表达无明显影响(P>0.05)。随访发现TPAP阴性为生存期的危险因素,阳性表达为生存期的保护因素。结论 TPAP对胰腺癌的发生、发展可能具有抑制作用,其高表达可作为胰腺癌生存期长的良性预测指标。 Objective To investigate the relationship between the expression of TPAP gene in pancreatic duetal adeno-carcinoma and its clinical features and prognosis.Methods The total RNA were extracted from 40tissue samples of pancreatic ductal adeno-carcinoma and corresponding adjacent pancreatic tissues,as from well as 5normal pancreatic tissues from autopsy.TAQMAN real-time PCR(RT-PCR)was used to detect the TPAP expression.The relationship between TPAP expression in pancreatic carcinoma tissues and the clinical pathologic parameters were analyzed.The Kaplan-Meier analysis was adopted to assess the relationship between prognosis and TPAP gene expression.Results The relative quantities(RQs)of TPAP mRNA in pancreatic carcinoma tissues[0.012(0.004,0.018)]were significantly lower than those in the corresponding adjacent pancreatic tissues[0.018(0.009,0.081)]and normal pancreatic tissues[0.74(0.457,0.891), P〈0.01].There were also significant differences between the latter two tissues(P〈0.001).The RQs of TPAP mRNA expression in pancreatic carcinoma tissues was negatively correlated with metastasis(r=-0.342,P=0.031),but positively correlated with pathological grades(r=0.371,P=0.018).However,the other clinical pathologic findings including tumor site,tumor size,serum CA19-9,serum CEA, TMN stage,lymphatic metastasis,age and gender had no influence on the TPAP mRNA expression(P〉0.05).What was more important, the results of Kaplan-Meier analysis showed that patients with high TPAP mRNA expression survived significantly longer than those with the low expression(P=0.004).Conclusion The TPAP mRNA expression may suppress the pancreatic carcinoma development,and its high expression may be a positive predictor of long-term survival of pancreatic carcinoma patients.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2010年第12期1475-1477,共3页 Medical Journal of Chinese People's Liberation Army
基金 国家科技支撑计划课题(2006BAI02A12)
关键词 胰腺肿瘤 基因 TPAP 预后 pancreatic neoplasms; gene,TPAP; prognosis
  • 相关文献

参考文献4

  • 1Larghi A, Verna EC, Lecca PG, etal. Screening for pancreatic cancer in high risk individuals: a call for endoscopic ultrasound[J]. Clin Cancer Res, 2009, 15(6): 1907-1914.
  • 2Zuckerman DS, Ryan DP. Adjuvant therapy for pancreatic cancer: a review[J]. Cancer, 2008, 112(2): 243-249.
  • 3Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2[J]. Science, 1995, 268(5212): 884- 886.
  • 4Bird A. Molecular biology-methylation talk between histones and DNA[J].Science, 2001, 294(5549): 2113-2115.

同被引文献20

  • 1盖宝东,高福智,李晓娜,房学东,郑泽霖.胰腺癌p16、Bcl-2、Bax和VEGF基因表达及新生血管密度计数的意义[J].吉林大学学报(医学版),2005,31(1):94-96. 被引量:6
  • 2骆晓鸿,钟必强,李再平.CA19-9、CA125和CEA检测在胰腺癌诊断中的应用[J].贵阳医学院学报,2006,31(1):76-76. 被引量:1
  • 3李兆申.胰腺癌研究进展[J].中国实用内科杂志:临床前沿版,2006,26(12):1921-1923. 被引量:6
  • 4Bertsch T, Aschenneller C, Bewarder N, et al. European proficiency study with control serum for the tumor marker CA19-9 measured on different test systems[ J]. Clin Lab ,2013,59 ( 1 - 2 ) : 185 - 192.
  • 5Jamieson NB, Carter CR, McKay CJ, et al. Tissue biumarkers for prognosis in pancreatic ductal adenocarcinoma:a systematic review and meta-analysis [ J ]. Clin Cancer Res, 2011,17 ( 10 ) :3316 - 3331.
  • 6Zhou G, Niu L, Chiu D, et al. Changes in the expression of serum markers CA242, CA19-9, CA125, CEA, TNF x03b1, and TSGF af-ter cryosurgery in pancreatic cancer patients [ J ]. Biotechnol Lett, 2012,34 (7) : 1235 - 1241.
  • 7Marten A,Buehler MW,Werft W,et al. Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology [ J ]. Immunother, 2010,33 ( 2 ) : 219 - 224.
  • 8Gunkel, L; Mylonas I, Richter DU, et al. Immunohistochemical studies of mucinous mammary carcinomas and their metastases [ J ]. Anticancer Res ,2005,25 (3A) : 1755 - 1759.
  • 9Falzarano R, Viggiani V, Michienzi S, et al. CLEIA CA125 evi- dences : good analytical performance avoiding "Hook effect" [ J ]. Tumour Biol,2013,34( 1 ) :387 -393.
  • 10Yang XQ, Chen C, Peng CW, et al. Carbohydrate antigen 242 high- ly consists with carbohydrate antigen 19-9 in diagnosis and progno- sis of eolorectal cancer:study on 185 cases[ J]. Med Oncol,2012, 29(2) :1030 - 1036.

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部